weight gain after stopping semaglutide Woman shares journey of loss and using The Data Are Clear: Patients
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 13.Horvth L., Mrz M., Jude E.B., Haluzk M
Impressive findings from the STEP [24], SURMOUNT [25] and SELECT [16] trials have led to the licencing and widespread use of GLP-1/dual receptor agonists for the treatment of obesity
Some lose their appetite entirely, struggling to eat more than once or twice a dayraising risk of malnutrition
Why Patients Stop GLP-1 Therapy in Real-World Practice Side Effects, Cost, and Expectations One of the most common reasons patients struggle to stay on GLP-1 therapy is gastrointestinal discomfort
